Patents by Inventor Hervé Minoux

Hervé Minoux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted thieno[2,3-c]pyrazoles, process for preparing them, compositions containing them, and use thereof
    Patent number: 7884123
    Abstract: Compounds of formula (I), wherein R1 and R3 have the meanings given in the description, said compounds being in all isomeric forms; and salts thereof; processes for the preparation of the compounds and intermediates; compositions containing them, and the use thereof as medicaments, particularly as anti-cancer agents.
    Type: Grant
    Filed: May 23, 2007
    Date of Patent: February 8, 2011
    Assignee: Aventis Pharma S.A.
    Inventors: Jean-Christophe Carry, Gilles Doerflinger, Antony Bigot, Dominique Barbalat-Damour, François Clerc, Arielle Genevois-Borella, Baptiste Ronan, Hervé Minoux, Claude Barberis, Yves Janin
  • Fluorene derivatives, composition containing said derivatives and the use thereof
    Patent number: 7674795
    Abstract: This invention relates to derivatives of 4-(benzimidazol-2-yl)fluorene and 4-(azabenzimidazol-2-yl)fluorene, to pharmaceutical compositions comprising such derivatives, and to methods of treatment of disorders related to Hsp90 protein activity, comprising administering such derivatives.
    Type: Grant
    Filed: November 14, 2007
    Date of Patent: March 9, 2010
    Assignee: Aventis Pharma SA
    Inventors: Patrick Mailliet, Luc Bertin, Fabienne Thompson, Jean-Marie Ruxer, Fabienne Pilorge, Didier Benard, Hervé Minoux, Chantal Carrez, Hélène Goulaouic, Thierry Gouyon
  • Organophosphorus derivatives of indazoles and use thereof as medicinal products
    Patent number: 7491710
    Abstract: The present invention relates in particular to novel chemical compounds, particularly to novel organophosphorus derivatives of indazoles, to the compositions containing them, and to the use thereof as medicinal products for treating cancers.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: February 17, 2009
    Assignee: Aventis Pharma S.A.
    Inventors: Marie-Pierre Cherrier, Francois Clerc, Alain Commercon, Patrick Mailliet, Hervé Minoux, Bruno Filoche-Rommé